XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders' Equity (Tables)
6 Months Ended
Jun. 30, 2023
Stockholders Equity [Abstract]  
Schedule of Stock-Based Compensation Expense The Company recognized stock-based compensation expense during the three and six months ended June 30, 2023 and 2022 as follows:
   For the three months ended
June 30,
   For the six months ended
June 30,
 
   2023   2022   2023   2022 
Performance-based restricted stock awards  $166,779   $187,648   $333,558   $353,924 
Service-based restricted stock awards   19,997    248,086    49,992    305,586 
Stock issued to consultants   
-
    
-
    307,069    
-
 
Common stock warrant expense   500,500    500,500    1,001,000    667,333 
Total stock-based compensation  $687,276   $936,234   $1,691,619   $1,326,843 
Schedule of Restricted Stock Awards Activity The following table presents a summary of the Company’s performance-based awards restricted stock awards activity:
   Number of
shares
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Life (in
years)
   Aggregate
Intrinsic
Value
 
Outstanding as of December 31, 2022   342,310    
 -
    8.33   $472,388 
Issued   
-
    
-
           
Exercised   (100,000)   
-
         318,000 
Expired   
-
    
-
           
Outstanding as of June 30, 2023   242,310    
-
    9.04   $457,966 
Exercisable as of June 30, 2023   144,327    
-
    4.97   $272,778 

 

Schedule of Service-Based Awards The following table presents a summary of the Company’s service-based awards activity:
   Number of
shares
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Life
(in years)
   Aggregate
Intrinsic
Value
 
Outstanding as of December 31, 2022   74,246    
 -
    8.42    102,459 
Issued   4,140,720    
-
           
Exercised   (13,760)   
-
         43,744 
Expired   
-
    
-
           
Outstanding as of June 30, 2023   4,201,206    
-
    2.84    7,940,279 
Exercisable as of June 30, 2023   60,486    
-
    0.13    114,319 
Schedule of Stock Options Awards Activity The following table presents a summary of the Company’s Stock options awards activity:
   Number of
shares
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Life
(in years)
 
Outstanding as of December 31, 2022   417   $35.90    1.26 
Issued   1,750,000    1.89      
Exercised   
-
    
-
      
Expired   
-
    
-
      
Outstanding as of June 30, 2023   1,750,417   $1.90    10.0 
Exercisable as of June 30, 2023   417   $35.90    1.26 

 

Schedule of Outstanding Stock Warrants A summary of the status of the Company’s outstanding stock warrants and changes during the six months ended June 30, 2023, is as follows:
   Number of
Warrants
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Life
(in years)
 
Outstanding as of December 31, 2022   2,825,278           
Issued   2,967,512    14.31    3.69 
Exercised   (246,668)   
-
    
-
 
Expired   
-
    
-
    
-
 
Outstanding as of June 30, 2023   5,546,122   $14.31    3.39 
Warrants exercisable as of June 30, 2023   5,546,122   $14.31    3.69